Histologic and immunohistologic characterization of skin localization of myeloid disorders a study of 173 cases

American Journal of Clinical Pathology

Volumn 135, Issue 2, 2011, Pages 278-290

  Bénet, Claire ^a   Gomez, Aurélie ^b   Aguilar, Claire ^c   Delattre, Claire ^d   Vergier, Béatrice ^e   Beylot Barry, Marie ^e,f   Fraitag, Sylvie ^c   Carlotti, Agnès ^g   Dechelotte, Pierre ^h   Hospital, Valérie ⁱ   D'Incan, Michel ⁱ   Costes, Valérie ^e   Dereure, Olivier ^j   Ortonne, Nicolas ^f,i,j,k   Bagot, Martine ^l   Laroche, Liliane ^m   Blom, Astrid ^m   Dalac, Sophie ^a   Petrella, Tony ^a,n,o  

^a DIJON UNIVERSITY HOSPITAL   (France)

^b Hematology Service   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d LILLE UNIVERSITY HOSPITAL   (France)

^e Anatomic Pathology Laboratory   (France)

^f HAUT LÉVÊQUE HOSPITAL   (France)

^g Institut Cochin   (France)

^h Anatomic Pathology Service   (France)

ⁱ UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^j MONTPELLIER UNIVERSITY HOSPITAL   (France)

^k HENRI MONDOR HOSPITAL   (France)

^l SAINT LOUIS HOSPITAL   (France)

^m AVICENNE HOSPITAL   (France)

ⁿ Pathology Center   (France)

^o Dept of Pathology   (France)

more..

Author keywords

CD123; CD33; CD68; Chronic myelomonocytic leukemia; Immunohistochemistry; Morphology; Myeloid leukemia cutis; Plasmacytoid dendritic cell

Indexed keywords

ANTIGEN; CD123 ANTIGEN; CD14 ANTIGEN; CD163 ANTIGEN; CD303 ANTIGEN; CD33 ANTIGEN; CD34 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD68 ANTIGEN; KI 67 ANTIGEN; MYELOPEROXIDASE; STEM CELL FACTOR RECEPTOR; UNCLASSIFIED DRUG; CD68 ANTIGEN, HUMAN; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN; PEROXIDASE; TUMOR MARKER;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ANEMIA; ARTICLE; CANCER LOCALIZATION; CELL STRUCTURE; CHILD; CHRONIC MYELOMONOCYTIC LEUKEMIA; CYTOGENETICS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; MAJOR CLINICAL STUDY; MALE; MYELOID LEUKEMIA; MYELOID LEUKEMIA CUTIS; MYELOPROLIFERATIVE DISORDER; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SCORING SYSTEM; SKIN BIOPSY; SKIN DEFECT; TUMOR CELL; CLINICAL TRIAL; GENETICS; IMMUNOPHENOTYPING; MIDDLE AGED; MULTICENTER STUDY; NEWBORN; PATHOLOGY; REFRACTORY ANEMIA; SKIN TUMOR;

AGED; AGED, 80 AND OVER; ANEMIA, REFRACTORY; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; FEMALE; HUMANS; IMMUNOPHENOTYPING; INFANT, NEWBORN; LEUKEMIA, MYELOID; LEUKEMIA, MYELOID, ACUTE; LEUKEMIA, MYELOMONOCYTIC, CHRONIC; MALE; MIDDLE AGED; PEROXIDASE; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 79952263253     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCPFMNYCVPDEND0     Document Type: Article

References (39)

1. Desch JK, Smoller BR. The spectrum of cutaneous disease in leukemias. J Cutan Pathol. 1993;20:407-410. (Pubitemid 23332277)
2. Agis H, Weltermann A, Fonatsch C, et al. A comparative study on demographic, hematological, and cytogenetic findings and prognosis in acute myeloid leukemia with and without leukemia cutis. Ann Hematol. 2002;81:90-95. (Pubitemid 36067582)
3. Bennett JM, Catovsky D, Daniel MT, et al, for the French-American-British (FAB) Co-operative Group. Proposals for the classification of the acute leukaemias. Br J Haematol. 1976;33:451-458.
4. Bennett JM, Catovsky D, Daniel MT, et al. Proposed revised criteria for the classification of acute myeloid leukemia: a report of the French-American-British Cooperative Group. Ann Intern Med. 1985;103:620-625.
5. Cronin DM, George TI, Sundram UN. An updated approach to the diagnosis of myeloid leukemia cutis. Am J Clin Pathol. 2009;132:101-110.
6. Cibull TL, Thomas AB, O'Malley DP, et al. Myeloid leukemia cutis: a histologic and immunohistochemical review. J Cutan Pathol. 2008;35:180-185.
7. Seckin D, Senol A, Gurbuz O, et al. Leukemic vasculitis: an unusual manifestation of leukemia cutis. J Am Acad Dermatol. 2009;61:519-521.
8. Hattori T, Amano H, Nagai Y, et al. Leukemia cutis in a patient with acute monocytic leukemia presenting as unique facial erythema. J Dermatol. 2008;35:671-674.
9. Kaune KM, Baumgart M, Schmitke E, et al. Papular exanthem discloses acute myeloid leukaemia: interphase fluorescence in situ hybridization revealed deletion of p53 and gain at 8q22/8q24/Tel8q without trisomy 8 [published online ahead of print May 5, 2009]. Clin Exp Dermatol. 2010;35:160-164.
10. Hejmadi RK, Thompson D, Shah F, et al. Cutaneous presentation of aleukemic monoblastic leukemia cutis: a case report and review of literature with focus on immunohistochemistry. J Cutan Pathol. 2008;35(suppl 1):46-49.
11. Angulo J, Haro R, Gonzalez-Guerra E, et al. Leukemia cutis presenting as localized cutaneous hyperpigmentation. J Cutan Pathol. 2008;35:662-665. (Pubitemid 351813405)
12. Requena L, Kutzner H, Palmedo G, et al. Histiocytoid Sweet syndrome: a dermal infiltration of immature neutrophilic granulocytes. Arch Dermatol. 2005;141:834-842. (Pubitemid 41058064)
13. Kempf W, Ostheeren-Michaelis S, Paulli M, et al. Granulomatous mycosis fungoides and granulomatous slack skin: a multicenter study of the Cutaneous Lymphoma Histopathology Task Force Group of the European Organization for Research and Treatment of Cancer (EORTC). Arch Dermatol. 2008;144:1609-1617.
14. Baksh FK, Nathan D, Richardson W, et al. Leukemia cutis with prominent giant cell reaction. Am J Dermatopathol. 1998;20:48-52. (Pubitemid 28092706)
15. Kaddu S, Zenahlik P, Beham-Schmid C, et al. Specific cutaneous infiltrates in patients with myelogenous leukemia: a clinicopathologic study of 26 patients with assessment of diagnostic criteria. J Am Acad Dermatol. 1999;40:966-978. (Pubitemid 29268929)
16. Su WP, Buechner SA, Li CY. Clinicopathologic correlations in leukemia cutis. J Am Acad Dermatol. 1984;11:121-128.
17. Lengerke C, Wirths S, Kanz L, et al. Unusual leukemia presentations, case 1: pulmonary chloroma preceded by leukemia cutis 7 years earlier. J Clin Oncol. 2005;23:5837-5839.
18. Martinez-Poventud G, Fradera J, Perez S, et al. Aleukemic leukemia cutis preceding acute monocytic leukemia: a case report. P R Health Sci J. 2008;27:256-258.
19. Bachmeyer C, Turc Y, Fraitag S, et al. Aleukemic monoblastic leukemia cutis [in French]. Ann Dermatol Venereol. 2003;130:773-775. (Pubitemid 37271252)
20. Barzilai A, Lyakhovitsky A, Goldberg I, et al. Aleukemic monocytic leukemia cutis. Cutis. 2002;69:301-304. (Pubitemid 41766311)
21. Kanegane H, Nomura K, Abe A, et al. Spontaneous regression of aleukemic leukemia cutis harboring a NPM/RARA fusion gene in an infant with cutaneous mastocytosis. Int J Hematol. 2009;89:86-90.
22. Landers MC, Malempati S, Tilford D, et al. Spontaneous regression of aleukemia congenital leukemia cutis. Pediatr Dermatol. 2005;22:26-30. (Pubitemid 40175998)
23. Pileri SA, Ascani S, Cox MC, et al. Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients. Leukemia. 2007;21:340-350. (Pubitemid 46158129)
24. Newell JO, Cessna MH, Greenwood J, et al. Importance of CD117 in the evaluation of acute leukemias by flow cytometry. Cytometry B Clin Cytom. 2003;52:40-43. (Pubitemid 38297643)
25. Wells SJ, Bray RA, Stempora LL, et al. CD117/CD34 expression in leukemic blasts. Am J Clin Pathol. 1996;106:192-195. (Pubitemid 26277207)
26. Di Bona E, Sartori R, Zambello R, et al. Prognostic significance of CD56 antigen expression in acute myeloid leukemia. Haematologica. 2002;87:250-256. (Pubitemid 34212440)
27. Petrella T, Teitell MA, Spiekermann C, et al. A CD56-negative case of blastic natural killer-cell lymphoma (agranular CD4+/CD56+ haematodermic neoplasm). Br J Dermatol. 2004;150:174-176. (Pubitemid 38234040)
28. Facchetti F, Vermi W, Santoro A, et al. Neoplasms derived from plasmacytoid monocytes/interferon-producing cells: variability of CD56 and granzyme B expression [letter]. Am J Surg Pathol. 2003;27:1489-1492.
29. Petrella T, Comeau MR, Maynadie M, et al. "Agranular CD4+ CD56+ hematodermic neoplasm" (blastic NK-cell lymphoma) originates from a population of CD56+ precursor cells related to plasmacytoid monocytes. Am J Surg Pathol. 2002;26:852-862. (Pubitemid 34752173)
30. Müller-Hermelink HK, Stein H, Steinmann G, et al. Malignant lymphoma of plasmacytoid T-cells: morphologic and immunologic studies characterizing a special type of T-cell. Am J Surg Pathol. 1983;7:849-862. (Pubitemid 14222471)
31. Khoury JD, Medeiros LJ, Manning JT, et al. CD56+ TdT+ blastic natural killer cell tumor of the skin: a primitive systemic malignancy related to myelomonocytic leukemia. Cancer. 2002;94:2401-2408. (Pubitemid 34457121)
32. Herling M, Teitell MA, Shen RR, et al. TCL1 expression in plasmacytoid dendritic cells (DC2s) and the related CD4+ CD56+ blastic tumors of skin. Blood. 2003;101:5007-5009. (Pubitemid 36857765)
33. Facchetti F, Jones D, Petrella T. Blastic plasmacytoid dendritic cell neoplasm. In: Swerdlow SH, Campo E, Harris NL, et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: IARC Press; 2008: 145-147.
34. Petrella T, Facchetti F. Tumoral aspects of plasmacytoid dendritic cells: what do we know in 2009? Autoimmunity. 2010;43:210-214.
35. Vermi W, Facchetti F, Rosati S, et al. Nodal and extranodal tumor-forming accumulation of plasmacytoid monocytes/interferon-producing cells associated with myeloid disorders. Am J Surg Pathol. 2004;28:585-595. (Pubitemid 38579559)
36. Orazi A, Chiu R, O'Malley DP, et al. Chronic myelomonocytic leukemia: the role of bone marrow biopsy immunohistology. Mod Pathol. 2006;19:1536-1545. (Pubitemid 44789921)
37. Harris NL, Demirjian Z. Plasmacytoid T-zone cell proliferation in a patient with chronic myelomonocytic leukemia: histologic and immunohistologic characterization. Am J Surg Pathol. 1991;15:87-95.
38. Orazi A, Bennett JM, Germing U, et al. Chronic myelomonocytic leukaemia. In: Swerdlow SH, Campo E, Harris NL, et al, eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: IARC Press; 2008: 76-79.
39. Cho-Vega JH, Medeiros LJ, Prieto VG, et al. Leukemia cutis. Am J Clin Pathol. 2008;129:130-142. (Pubitemid 352038602)